Detalles de la búsqueda
1.
Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts.
J Immunother;
29(5): 536-44, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16971809
2.
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line.
Blood;
104(1): 178-83, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15001473
Resultados
1 -
2
de 2
1
Próxima >
>>